⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23634162 | 0.81 | SLC1A3 (0.33) | — | |
| SCHEMBL17811759 | 0.80 | EPHX2 (0.32) | — | |
| SCHEMBL20021701 | 0.78 | SLC1A3 (0.34) | — | |
| SCHEMBL23588378 | 0.78 | — | — | |
| SCHEMBL17812433 | 0.78 | — | — | |
| SCHEMBL21466437 | 0.76 | EPHX2 (0.30) | — | |
| SCHEMBL12541302 | 0.76 | SLC1A3 (0.39) | — | |
| SCHEMBL18883522 | 0.76 | SLC1A3 (0.39) | — | |
| SCHEMBL13452 | 0.76 | — | — | |
| SCHEMBL18883524 | 0.76 | SLC1A3 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230365556-A1 | N-ACYL AMINO ACID COMPOUNDS AND METHODS OF USE | PLIANT THERAPEUTICS, INC. (US) | 2023-11-16 | — | — | US | disclosed |
| US-11673887-B2 | N-acyl amino acid compounds and methods of use | PLIANT THERAPEUTICS, INC. (US) | 2023-06-13 | — | — | US | disclosed |
| US-20180093984-A1 | N-ACYL AMINO ACID COMPOUNDS AND METHODS OF USE | PLIANT THERAPEUTICS, INC. | 2018-04-05 | — | — | US | disclosed |